Topex Neutral Fluoride Foam
Sodium Fluoride
Dentsply Llc. Professional Division Trading As "sultan Healthcare"
Human Prescription Drug
NDC 0699-0155Topex Neutral Fluoride Foam also known as Sodium Fluoride is a human prescription drug labeled by 'Dentsply Llc. Professional Division Trading As "sultan Healthcare"'. National Drug Code (NDC) number for Topex Neutral Fluoride Foam is 0699-0155. This drug is available in dosage form of Aerosol, Foam. The names of the active, medicinal ingredients in Topex Neutral Fluoride Foam drug includes Sodium Fluoride - .02 g/g . The currest status of Topex Neutral Fluoride Foam drug is Active.
Drug Information:
| Drug NDC: | 0699-0155 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Topex Neutral Fluoride Foam |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Prescription Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Sodium Fluoride |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Dentsply Llc. Professional Division Trading As "sultan Healthcare" |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Aerosol, Foam |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | SODIUM FLUORIDE - .02 g/g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | DENTAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 Jan, 1997 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Dentsply LLC. Professional Division Trading as "Sultan Healthcare"
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 688393
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0306990155448
|
| UPC stands for Universal Product Code. |
| UNII: | 8ZYQ1474W7
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 0699-0155-44 | 1 CANISTER in 1 CARTON (0699-0155-44) / 125 g in 1 CANISTER | 01 Jan, 1997 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Product Elements:
Topex neutral fluoride foam sodium fluoride sodium fluoride fluoride ion polyethylene glycol 400 water benzaldehyde sodium methyl cocoyl taurate cetyl alcohol apaflurane sodium benzoate saccharin sodium diethanolamine oleth-10 phosphate diethanolamine oleth-3 phosphate sodium phosphate, dibasic, anhydrous mixed berry
Indications and Usage:
Indications and usage topex® fluoride foams are indicated for topical application to teeth to aid in the prevention of dental caries. the non-acidic nature of neutral ph (naf) is recommended for patients with ceramic or composite restorations.
Warnings and Cautions:
Warnings and precautions do not swallow. harmful if swallowed. keep out of reach of children. this product is not intended for home or unsupervised consumer use. contents under pressure. do not puncture or incinerate canister. safety and effectiveness below age 3 have not been established. there have been no long-term animal studies with this product to evaluate carcinogenic, mutagenic, or impairment of fertility potential. laboratory studies have indicated that repeated use of apf may dull porcelain, composite restorations and sealants.
Dosage and Administration:
Dosage and adminstration 1. remove cap from can. if this is the first time using can, break the protective shipping tab by gently lifting up the trigger. 2. shake can thoroughly for at least 10 seconds before each use. 3. completely invert can and slowly depress trigger to dispense foam into a fluoride tray 4. air dry teeth thoroughly and insert tray into patientâs mouth. have patient close into the tray and use a slight chewing motion to ensure interproximal coverage. 5. leave tray in contact with teeth between 1-4 minutes. use a saliva ejector during treatment to minimize ingestion of product 6. remove tray after elapsed time and have patient expectorate. instruct patient to refrain from drinking, eating, or rinsing for 30 minutes after treatment. treatment frequency should not exceed 4 treatments per year.
Dosage Forms and Strength:
Dosage forms and strengths apf topical foam contains 2.73% sodium fluoride (1.23% fluoride ion). naf topical gel contains 2.0% sodium fluoride (0.9% fluoride ion).
Contraindications:
Contraindications hypersensitivity to fluoride. do not use if patient has a known allergy to fluoride or any of the other ingredients in this product.
Adverse Reactions:
Adverse reactions developing teeth of children under age 6 may become permanently discolored if excessive amounts are repeatedly swallowed. the following adverse reactions are possible in individuals hypersensitive to fluoride: eczema, atopic dermatitis, urticarial, gastric distress, headache, and weakness.
Overdosage:
Overdosage if treatment dose is swallowed (less than 100 mg f ion), administer milk, limewater, or calcium-type antacid. in case of larger doses, use ipecac syrup emetic and immediately seek medical help. overdose symptoms include nausea, vomiting, diarrhea, and abdominal pain.
Description:
Description topex® fluoride foams are a family of topical fluoride foam products for professional application in trays. the family consists of apf foam (1.23% fluoride ion at a ph between 3.0-4.5) and neutral ph foam (0.9% fluoride ion at a ph between 6.5 -7.5). topex® foam fluoride products do not contain chlorofluorocarbon propellants.
Package Label Principal Display Panel:
Principal display panel - mixed berry mixed berry